Literature DB >> 7496843

Autologous deposit of blood by oncology patients: an evaluation of actual use and wastage.

S P Shaheen1, B Lichtiger.   

Abstract

BACKGROUND: Transfusions of autologous deposited blood have continued to grow since the 1980s. Together with the growth in the deposit of autologous blood, issues such as appropriateness of indications, reimbursement, cost effectiveness, etc., have emerged and require addressing. Also, the patient's concerns about safety of the blood supply must be taken into account.
METHODS: We conducted a 20-week study to determine the collection and transfusion/wastage of autologous blood and the need to transfuse additional allogeneic units of packed red blood cells. The disposition of every autologous unit was followed until its disposal.
RESULTS: One hundred fifty-seven patients deposited 260 units of autologous blood. Of these, 144 units (55.4%) were transfused whereas 44.6% were discarded. In addition, 25 or 157 patients (15.9%) received an additional 58 units of allogeneic blood.
CONCLUSION: These data demonstrate that there are surgical procedures where autologous blood is drawn unnecessarily whereas others could afford a higher number of autologous blood deposits. Physicians may be pressured by patients into ordering autologous blood deposits, to allay fear of patients about safety of the blood supply. It is important that health care professionals undergo periodic education to be able to address patient's apprehension about safety of the blood supply.

Entities:  

Mesh:

Year:  1995        PMID: 7496843     DOI: 10.1007/bf02306381

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  15 in total

Review 1.  Preoperative autologous blood donation.

Authors:  L A Chambers; M S Kruskall
Journal:  Transfus Med Rev       Date:  1990-01

2.  Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use.

Authors:  D V Owings; M S Kruskall; R L Thurer; L M Donovan
Journal:  JAMA       Date:  1989-10-13       Impact factor: 56.272

3.  Intraoperative autologous transfusion in orthopaedic patients.

Authors:  J A Goulet; T J Bray; L A Timmerman; D R Benson; W L Bargar
Journal:  J Bone Joint Surg Am       Date:  1989-01       Impact factor: 5.284

4.  Establishment of a schedule of optimal preoperative collection of autologous blood.

Authors:  F B Axelrod; S H Pepkowitz; D Goldfinger
Journal:  Transfusion       Date:  1989-10       Impact factor: 3.157

5.  Predeposited autologous blood for elective surgery. A national multicenter study.

Authors:  P T Toy; R G Strauss; L C Stehling; R Sears; T H Price; E C Rossi; M L Collins; J P Crowley; R S Eisenstaedt; L T Goodnough
Journal:  N Engl J Med       Date:  1987-02-26       Impact factor: 91.245

6.  Cost comparison of intraoperative autologous versus homologous transfusion.

Authors:  M D Solomon; M L Rutledge; L E Kane; D H Yawn
Journal:  Transfusion       Date:  1988 Jul-Aug       Impact factor: 3.157

7.  Transfusion of predonated autologous blood in elective cardiac surgery.

Authors:  T R Love; W G Hendren; D D O'Keefe; W M Daggett
Journal:  Ann Thorac Surg       Date:  1987-05       Impact factor: 4.330

8.  Autologous transfusions for cancer patients undergoing elective ablative surgery.

Authors:  B Lichtiger; Y O Huh; M Armintor; H E Fischer
Journal:  J Surg Oncol       Date:  1990-01       Impact factor: 3.454

9.  Autologous transfusions. Experience in a community blood center.

Authors:  A J Silvergleid
Journal:  JAMA       Date:  1979-06-22       Impact factor: 56.272

10.  A large-scale autologous blood program in a community hospital. A contribution to the community's blood supply.

Authors:  R K Haugen; G E Hill
Journal:  JAMA       Date:  1987-03-06       Impact factor: 56.272

View more
  1 in total

Review 1.  Anemia and transfusions in patients undergoing surgery for cancer.

Authors:  Randal S Weber; Nicolas Jabbour; Robert C G Martin
Journal:  Ann Surg Oncol       Date:  2007-10-18       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.